7 results
424B5
Teva Pharmaceutical Finance Netherlands II B.V.
4 Nov 21
Prospectus supplement for primary offering
4:41pm
materiality assessment to identify our Environmental, Social and Governance (“ESG”) priorities and objectives. We issued our 2020 ESG Progress Report
424B3
s6h1 5z8ekpkfi
27 Oct 21
Prospectus supplement
8:51am
- Prev
- 1
- Next